Neovest fine stokes the EMS transaction fee debate
The SEC’s fine for J.P. Morgan’s Neovest could signal a shift in how the industry views contentious EMS transaction fees. Chartis’ research shows that, as regulatory pressure mounts, investment managers and vendors may have to rethink their transaction-fee strategies.
EMS transaction fees: benefit or bane?On 28 June the Securities and Exchange Commission (SEC) announced that it had levied a fine on Neovest, a division of JPMorgan Chase, for operating as an unregistered broker-dealer
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@risk.net
More on Financial Risk
RiskTech100® Winner’s Profile: Moody's
Moody’s celebrates its first year at the top of the RiskTech100 rankings. This marks a stellar year for the Overall Winner, with the firm taking home 15 additional individual awards, its largest haul in the 17-year history of the RiskTech100.
RiskTech100® Rising Star Profile: Vneuron
Vneuron Risk & Compliance is a ‘Rising Star’ in this year’s Chartis’ RiskTech100 awards. The fast-growing, French-headquartered firm is on a mission to fight money laundering and combat terrorism financing. It has been recognized by Chartis for the…
Vendor Analysis - Wolters Kluwer (CCH® Tagetik): IFRS 17 and LDTI Solutions, 2022
This Vendor Analysis summarizes the key theses in Chartis' IFRS 17/LDTI quadrant report, and takes a detailed look at Wolters Kluwer's quadrant positioning and scoring, and Chartis’ underlying opinion and analysis.
Credit Data Solutions, 2022: Market and Vendor Landscape
This report focuses on three segments of the credit data ecosystem: wholesale, retail, and CRE/property services.
Chartis Big Bets 2022
Chartis’ annual Big Bets report outlines our major predictions for the year ahead, highlighting some of the key market trends, risk areas and core technologies that form the basis of our 2022 report agenda.
Enterprise Management Tech and Trends Fireside Chat with Sidhartha Dash- -Part Two
Enterprise fraud management is a serious topic for any organization. While it is an ever-changing sector to keep up with the latest threats and global regulatory measures, there are elements that remain constant. With that in mind, Sidhartha Dash and TJ…